Á lódáil...
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
Angiogenesis has always been the topic of major scientific interest in the field of malignant tumors. Nowadays, targeting angiogenesis has achieved success in various carcinomas by several mechanisms, including the use of anti-angiogenic small molecule receptor tyrosine kinase inhibitors (TKIs). The...
Na minha lista:
| Foilsithe in: | J Hematol Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
BioMed Central
2019
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6417086/ https://ncbi.nlm.nih.gov/pubmed/30866992 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-019-0718-5 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|